Bristol-Myers Squibb Q3 Earnings Outlook

Bristol-Myers Squibb Company BMY unveils its next round of earnings this Thursday, Oct. 25. Here is Benzinga's everything-that-matters guide for the Q3 earnings announcement

Earnings and Revenue

Bristol-Myers Squibb EPS will likely be near 91 cents while revenue will be around $5.72 billion, according to analysts.

In the same quarter last year, Bristol-Myers Squibb reported EPS of 75 cents on revenue of $5.25 billion. The Wall Street estimate would represent a 21.33 percent increase in the company's earnings. Revenue would be up 8.87 percent from the year-ago period. Here's how the company's reported EPS has stacked up against analyst estimates in the past:

Stock Performance

Over the last 52-week period, shares are down 21.38 percent. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release.

Analyst estimates are adjusted higher for EPS and revenues over the past 90 days. The most common rating from analysts on Bristol-Myers Squibb stock is a Neutral. The strength of this rating has maintained conviction over the past three months.